URGN
UroGen Pharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
URGN fundamentals
UroGen Pharma (URGN) released its earnings on Nov 6, 2025: revenue was 27.48M (YoY +9.03%), missed estimates; EPS was -0.69 (YoY -25.45%), missed estimates.
Revenue / YoY
27.48M
+9.03%
EPS / YoY
-0.69
-25.45%
Report date
Nov 6, 2025
URGN Earnings Call Summary for Q3,2025
- ZUSDURI Early Momentum: $1.8M Q3 sales, $4.5M October demand revenue, with 45-60 day PEF-to-treatment lag.
- JELMYTO Growth: 13% YoY revenue increase, solidifying as standard of care.
- Pipeline Progress: UGN-103 NDA submission planned for H2 2026, UGN-501 Phase I in 2026.
- Financial Health: $127M cash, 2025 JELMYTO guidance of $94-98M, no immediate capital needs.
- Strategic Focus: Permanent J-code launch in January 2026 to accelerate ZUSDURI adoption.
EPS
Revenue
Revenue & Expenses
URGN has released its 2025 Q3 earnings report, with revenue of 27.48M, reflecting a YoY change of 9.04%, and net profit of -33.35M, showing a YoY change of -40.87%. The Sankey diagram below clearly presents URGN's revenue sources and cost distribution.
Key Indicators
UroGen Pharma (URGN) key financial stats and ratios, covering profitability, financial health, and leverage.
UroGen Pharma (URGN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
UroGen Pharma (URGN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
UroGen Pharma (URGN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does UroGen Pharma (URGN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track UroGen Pharma (URGN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is UroGen Pharma's latest dividend and current dividend yield?What does UroGen Pharma do and what are its main business segments?What guidance did UroGen Pharma's management provide for the next earnings period?What is the market's earnings forecast for UroGen Pharma next quarter?What factors drove the changes in UroGen Pharma's revenue and profit?What is the revenue and EPS growth rate for UroGen Pharma year over year?What were the key takeaways from UroGen Pharma’s earnings call?Did UroGen Pharma beat or miss consensus estimates last quarter?
